A preliminary analysis did not reveal significant differences in gene expression of classical ER-target genes between ER+ tumors with hypo-methylated vs hyper-methylated ESR1 (data not shown), but we plan on performing additional studies, including detailed analyses of different expression, methylation and roles of ER in breast cancer. The gene discussed is ESR1; the disease is breast carcinoma.